3 key vaccine production challenges drugmakers are facing

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 18, 2020 at 11:12 PM.

  1. #1 cafead, Nov 18, 2020 at 11:12 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,057
    Likes Received:
    3
    via Pfizer and Moderna both recently said their COVID-19 vaccine candidates are 95 percent effective in preventing the disease. The news is encouraging, but the U.S. is still a long way from manufacturing enough doses to inoculate its residents on a mass scale.

    Below are three main challenges drugmakers are experiencing in their efforts to ramp up COVID-19 vaccine production.

    article source
     
    Quote

Reply to Thread